Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients

Balazs Jori, Rick Kamps, Sofia Xanthoulea, Bert Delvoux, Marinus J. Blok, Koen K. Van de Vijver, Bart de Koning, Felicia Trups Oei, Carli M. Tops, Ernst J. M. Speel, Roy F. Kruitwagen, Encarna B. Gomez-Garcia, Andrea Romano

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)41108-41122
JournalOncotarget
Volume6
Issue number38
DOIs
Publication statusPublished - 1 Dec 2015

Keywords

  • Lynch syndrome
  • endometrial cancer
  • genetic risk modifier
  • next generation sequencing
  • estrogens

Cite this